Perkins partners with Victor Chang Cardiac Research Institute for better heart outcomes
By Richard Schoonraad | Advanced Clinical and Translational Cardiovascular Imaging, Cardiovascular Disease, Cell Signalling, Community, Donation Handles, Media Releases, News & Events, Research, SarcomaThe Harry Perkins Institute of Medical Research has forged a new partnership with one of Australia’s leaders in heart research. The strategic partnership with the Victor Chang Cardiac Research Institute…
1000 Walkers take to the Streets for Women’s Cancer Research
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cancer Program, Community, Events, Media Releases, News & Events, Ovarian Cancer, Perkins Events, Walk for Women's CancerMore than 1000 Walkers hit the pavement this morning for the New Town Toyota Walk for Women’s Cancer, taking place at Riley Oval at UWA Crawley. The Walk benefits women’s…
New heart health trial targets families with history of early heart attacks
By Richard Schoonraad | Cardiovascular Research & Innovation, Cardiovascular Science and Diabetes Program, Cell Signalling, Community, Donation Handles, Heart, News & Events, Research, SarcomaA pioneering new study led by cardiologist Associate Professor Abdul Ihdayhid from the Harry Perkins Institute of Medical Research and Curtin University is offering new hope to families affected by…
Researchers discover blood markers that could predict mesothelioma treatment success
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer Epigenetics, Cancer Program, Cell Signalling, Lab, Mesothelioma, News & Events, ResearchA groundbreaking study by researchers at the National Centre for Asbestos Related Diseases (NCARD), The Kids Research Institute and the Harry Perkins Institute of Medical Research (the Perkins) has identified…
Lowering cancer drug dose could open tumours to immunotherapy
By Alicia Bienkowski | Brain, Cancer, Cancer, Disease Area, Lab, Media Releases, Melanoma Discovery, Melonoma, News & Events, Research, Research Area, Systems Biology and GenomicsGroundbreaking research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the…
World melanoma expert exposes sailor’s skin cancer risk
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Melanoma, Melanoma Discovery, Melonoma, News & Events, ResearchPerth based cancer researcher Professor Jonas Nilsson regularly sees in his laboratory just how damaging sun exposure is to our skin as he investigates ways to treat melanoma, the most…
New biomarker predicts liver cancer recurrence and immunotherapy response
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Disease Area, Immunotherapy, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research, Tumours, xOncofetal EcosystemAnalysis of the environment that surrounds liver cancer tumours has revealed that patients with a high concentration of a certain cell type have early return of aggressive cancer but do…
WA researchers excel in nationally competitive grants
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cardiovascular Disease, Cardiovascular Disease, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Media Releases, Mitochondrial disease, Mitochondrial Disease, Mitochondrial Medicine and Biology, News & Events, Research, TranslationEight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have…